Active ingredientGemifloxacinCat. No. P-G025-001CAS 175463-14-6Family · Pharmaceutical analytical standards
Gemifloxacin
A broad-spectrum fluoroquinolone antibiotic, approved in the United States in 2003 for community-acquired pneumonia and flare-ups of chronic bronchitis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Developed in South Korea, it was the first medicine from that country to win US FDA approval: at the time only nine other countries besides the United States had managed it.
Go to the active ingredient →Active ingredientGemifloxacinCat. No. P-G025-001CAS 175463-14-6
Active ingredientGemifloxacin MesylateCat. No. P-G025-002CAS 210353-53-0
Pharmacopoeial impurityGemifloxacin USP Related Compound BCat. No. P-G025-003
Pharmacopoeial impurityGemifloxacin USP Related Compound CCat. No. P-G025-004
Isotopically labelledGemifloxacin-13C-d2Cat. No. P-G025-006
Impurity4-Oxo GemifloxacinCat. No. P-G025-008CAS 284474-31-3
ImpurityGemifloxacin Impurity 1Cat. No. P-G025-009CAS 213672-25-4
ImpurityGemifloxacin Impurity 2Cat. No. P-G025-010No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.